Related Experiment Videos
Proliferating cell nuclear antigen expression in central nervous system neoplasms
A Allegranza1, S Girlando, G L Arrigoni
1Department of Neuropathology, C. Besta, Neurological Institute, Milan, Italy.
Summary
Proliferating cell nuclear antigen (PCNA) labeling index (LI) correlates with tumor grade and other proliferation markers in neuroglial tumors. PCNA LI is a valuable tool for glioma grading and retrospective studies.
Area of Science:
- Neuro-oncology
- Cell Biology
- Immunohistochemistry
Background:
- Proliferating cell nuclear antigen (PCNA) is a cell-cycle-regulated protein.
- PCNA labeling index (LI) correlates with other proliferation markers like Ki67 and bromodeoxyuridine (BrdU) incorporation.
- PCNA LI has potential prognostic value in neoplasms.
Purpose of the Study:
- To investigate the relationship between PCNA LI and histological grade in neuroglial tumors.
- To compare PCNA LI with other proliferation markers in central nervous system (CNS) neoplasms.
- To assess the utility of PCNA LI in grading gliomas.
Main Methods:
- Immunohistochemical staining for PCNA was performed on a series of neuroglial tumors.
- PCNA LI was correlated with histological grade and other reported proliferation indices (thymidine LI, BrdU LI, Ki67 LI).
- Intratumoral heterogeneity of PCNA distribution was observed in some glioblastomas.
Main Results:
- A significant correlation was found between PCNA LI and histological grade in neuroglial tumors.
- PCNA LI showed good correlation with thymidine LI, BrdU LI, and Ki67 LI.
- Neuroglial tumors with higher histological grades, such as metastases of small cell lung cancer and medulloblastomas, exhibited higher PCNA LI compared to low-grade astrocytomas and pleomorphic xanthoastrocytomas.
Conclusions:
- PCNA LI is a reliable marker for assessing proliferation in neuroglial tumors and correlates with histological grade.
- PCNA LI is higher than other markers as it reflects multiple cell cycle phases and has a longer half-life.
- PCNA LI is a valuable and easily applicable tool for grading gliomas, with potential for retrospective studies, but its prognostic value requires further validation.